Cargando…
Does choice of sedative agent affect duration of ICU stay, mortality or neurological outcome in patients undergoing therapeutic hypothermia?
Autores principales: | Gillies, M, Pratt, R, Borg, J, Brooks, J, Mckenzie, C, Tibby, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084286/ http://dx.doi.org/10.1186/cc7564 |
Ejemplares similares
-
Introduction of a remifentanil-based analgo-sedation protocol leads to a reduction of duration of mechanical ventilation and ICU stay in critically ill patients
por: Van den Bosch, J, et al.
Publicado: (2011) -
Prognosis of critical surgical patients depending on the duration of stay in the ICU
por: Santana-Cabrera, Luciano, et al.
Publicado: (2015) -
Dexmedetomidine for Sedation of Neonates with HIE Undergoing Therapeutic Hypothermia: A Single-Center Experience
por: O'Mara, Keliana, et al.
Publicado: (2018) -
Good neurological recovery at ICU discharge of asystole patients treated with induced mild hypothermia
por: Foedisch, M, et al.
Publicado: (2008) -
Hypothermia is an independent risk factor for prolonged ICU stay in coronary artery bypass surgery: an observational study
por: Wang, Yi-Chia, et al.
Publicado: (2023)